Development of a recombinant adeno-associated virus vector for human T lymphocyte- and natural killer cell-targeted gene therapy
Hendrik Jahnz, Martin V. Hamann, H.O. Kim, Yaping Sun, Natalia A. Salazar-Quiroz, Li Zhu, Sabrina M. Leddy, Umm E Swaiba, Carola Schneider, Daniel Foth, Niklas Beschorner, Priti Kumar, Ulrike C. Lange
This paper develops a CD7-targeted rAAV vector for efficient gene delivery to human T and NK cells, showing reduced off-target effects and improved transgene expression through genome optimization.
Human Gene Therapy · Sep 16, 2026Peer-reviewedMolecular Biology